/ / Johnson & Johnson halts development of RSV vaccine in midst of late-stage clinical trials

Johnson & Johnson halts development of RSV vaccine in midst of late-stage clinical trials

Edit
Janssen, the pharmaceutical division of the Johnson & Johnson companies, announced Wednesday that it will scrap development of a vaccine for respiratory syncytial virus, or RSV, in adults.

About Crazy-hacker

This is a short description in the author block about the author. You edit it by entering text in the "Biographical Info" field in the user admin panel.

0 comments:

Post a Comment

Subscribe to: Post Comments ( Atom )